University of Minnesota. Driven to Discover.
Baloxavir reduced flu symptoms by 1 day and reduced viral shedding.
Data from 3 flu seasons show obese adults shed the virus about 1.5 times longer than non-obese adults.
BARDA will provide $24 million in initial funds to 2 companies to advance tests for influenza A and B.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.